Tech Company Financing Transactions

AvenCell Funding Round

Novo Holdings, Blackstone and Eight Roads joined a $112 million Series B funding round for AvenCell. This VC investment round closed on 10/22/2024.

Transaction Overview

Company Name
AvenCell
Announced On
10/22/2024
Transaction Type
Venture Equity
Amount
$112,000,000
Round
Series B
Investors

Novo Holdings (Lead Investor) (Michael Bauer)

Blackstone

Eight Roads

F-Prime Capital (Nihal Sinha)

NYBC Ventures

Piper Heartland

Proceeds Purpose
The company intends to use the funds to accelerate clinical validation of its proprietary Universal Switchable CAR-T cell therapy platform, for the treatment of a wide range of hematologic malignancies and auto-immune diseases

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
500 Forge Road
Watertown, MA 02472
USA
Phone
(617) 941-7468
Website
www.avencell.com
Email Address
[email protected]
Overview
AvenCell Therapeutics, Inc. was recently launched by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics, Inc. and incorporated the clinical-stage biopharmaceutical company GEMoaB GmbH, now named AvenCell Europe GmbH. Our mission is to overcome the limitations of current CAR-T cell therapies by introducing the next generation of immunotherapies to patients, everywhere.
Profile
AvenCell LinkedIn Company Profile
Social Media
AvenCell Company Twitter Account
Company News
AvenCell News
Facebook
AvenCell on Facebook
YouTube
AvenCell on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Schiermeier
  Andrew Schiermeier LinkedIn Profile  Andrew Schiermeier Twitter Account  Andrew Schiermeier News  Andrew Schiermeier on Facebook
Chief Financial Officer
Babar Ghias
  Babar Ghias LinkedIn Profile  Babar Ghias Twitter Account  Babar Ghias News  Babar Ghias on Facebook
Chief Medical Officer
Tapan Maniar
  Tapan Maniar LinkedIn Profile  Tapan Maniar Twitter Account  Tapan Maniar News  Tapan Maniar on Facebook
Chief Scientific Officer
Armin Ehninger
  Armin Ehninger LinkedIn Profile  Armin Ehninger Twitter Account  Armin Ehninger News  Armin Ehninger on Facebook
Chief Technical Officer
Marc Cartellieri
  Marc Cartellieri LinkedIn Profile  Marc Cartellieri Twitter Account  Marc Cartellieri News  Marc Cartellieri on Facebook
Vice President
Manfred Klevesath
  Manfred Klevesath LinkedIn Profile  Manfred Klevesath Twitter Account  Manfred Klevesath News  Manfred Klevesath on Facebook
VP - Finance
Andrea Kistner
  Andrea Kistner LinkedIn Profile  Andrea Kistner Twitter Account  Andrea Kistner News  Andrea Kistner on Facebook
VP - Human Resources
Jill Rogers
  Jill Rogers LinkedIn Profile  Jill Rogers Twitter Account  Jill Rogers News  Jill Rogers on Facebook
VP - Operations
Susan Buttler
  Susan Buttler LinkedIn Profile  Susan Buttler Twitter Account  Susan Buttler News  Susan Buttler on Facebook
VP - Operations
Markus Orchowski
  Markus Orchowski LinkedIn Profile  Markus Orchowski Twitter Account  Markus Orchowski News  Markus Orchowski on Facebook
VP - R & D
Reynald Lescarbeau
  Reynald Lescarbeau LinkedIn Profile  Reynald Lescarbeau Twitter Account  Reynald Lescarbeau News  Reynald Lescarbeau on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/22/2024: Lumenuity venture capital transaction
Next: 10/22/2024: NEPC venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.